James Arthur Bristol, Director at Deciphera Pharmaceuticals, Inc. (DCPH), sold 49,900 shares at $39.24 ($2.0M) on 2019-08-13, disclosed to the SEC on 2019-08-13.
Open-market sale of $2.0M DCPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.24 | 11,513 | $452K | 22.7% |
| 2 | $39.24 | 11,513 | $452K | 22.7% |
| 3 | $40.50 | 12,687 | $514K | 25.8% |
| 4 | $40.50 | 12,687 | $514K | 25.8% |
| 5 | $42.05 | 700 | $29K | 1.5% |
| 6 | $42.05 | 700 |
| $29K |
| 1.5% |
| 7 | $42.90 | 100 | $4K | 0.2% |
| Total | $39.97 avg | 49,900 | $2.0M | 100% |
| Filing → |
| DCPH | SELL | 2021-04-14 | $1.3M | — | Filing → |
| DCPH | SELL | 2021-01-20 | $352K | — | Filing → |
| DCPH | SELL | 2020-10-13 | $2.5M | — | Filing → |